nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—BCHE—multiple sclerosis	0.848	1	CbGaD
Dipivefrin—BCHE—Triamcinolone—multiple sclerosis	0.0703	1	CbGbCtD
Dipivefrin—Bambuterol—BCHE—multiple sclerosis	0.0059	0.832	CrCbGaD
Dipivefrin—Epinephrine—TNF—multiple sclerosis	0.00119	0.168	CrCbGaD
Dipivefrin—Mydriasis—Prednisolone—multiple sclerosis	0.000642	0.0499	CcSEcCtD
Dipivefrin—Hypertension—Fingolimod—multiple sclerosis	0.000632	0.0492	CcSEcCtD
Dipivefrin—Stinging—Prednisolone—multiple sclerosis	0.000632	0.0491	CcSEcCtD
Dipivefrin—Stinging—Triamcinolone—multiple sclerosis	0.000581	0.0452	CcSEcCtD
Dipivefrin—ADRA2A—peripheral nervous system—multiple sclerosis	0.000578	0.106	CbGeAlD
Dipivefrin—Stinging—Dexamethasone—multiple sclerosis	0.000528	0.041	CcSEcCtD
Dipivefrin—Stinging—Betamethasone—multiple sclerosis	0.000528	0.041	CcSEcCtD
Dipivefrin—Conjunctivitis—Cladribine—multiple sclerosis	0.000516	0.0401	CcSEcCtD
Dipivefrin—Arrhythmia—Cladribine—multiple sclerosis	0.000426	0.0331	CcSEcCtD
Dipivefrin—Arrhythmia—Azathioprine—multiple sclerosis	0.000346	0.0269	CcSEcCtD
Dipivefrin—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.000339	0.0264	CcSEcCtD
Dipivefrin—Tachycardia—Cladribine—multiple sclerosis	0.000331	0.0257	CcSEcCtD
Dipivefrin—ACHE—medulla oblongata—multiple sclerosis	0.000321	0.0591	CbGeAlD
Dipivefrin—ACHE—midbrain—multiple sclerosis	0.000294	0.054	CbGeAlD
Dipivefrin—Pain—Cladribine—multiple sclerosis	0.00029	0.0225	CcSEcCtD
Dipivefrin—ACHE—spinal cord—multiple sclerosis	0.000286	0.0527	CbGeAlD
Dipivefrin—Arrhythmia—Mitoxantrone—multiple sclerosis	0.00028	0.0218	CcSEcCtD
Dipivefrin—Conjunctivitis—Prednisolone—multiple sclerosis	0.000279	0.0216	CcSEcCtD
Dipivefrin—Conjunctivitis—Triamcinolone—multiple sclerosis	0.000256	0.0199	CcSEcCtD
Dipivefrin—ADRA1A—brainstem—multiple sclerosis	0.000255	0.0469	CbGeAlD
Dipivefrin—Hypersensitivity—Cladribine—multiple sclerosis	0.00025	0.0194	CcSEcCtD
Dipivefrin—Hypertension—Mitoxantrone—multiple sclerosis	0.000236	0.0183	CcSEcCtD
Dipivefrin—Conjunctivitis—Dexamethasone—multiple sclerosis	0.000232	0.0181	CcSEcCtD
Dipivefrin—Conjunctivitis—Betamethasone—multiple sclerosis	0.000232	0.0181	CcSEcCtD
Dipivefrin—Arrhythmia—Prednisolone—multiple sclerosis	0.00023	0.0179	CcSEcCtD
Dipivefrin—ACHE—cerebellum—multiple sclerosis	0.000227	0.0418	CbGeAlD
Dipivefrin—BCHE—brainstem—multiple sclerosis	0.000226	0.0417	CbGeAlD
Dipivefrin—Tachycardia—Mitoxantrone—multiple sclerosis	0.000217	0.0169	CcSEcCtD
Dipivefrin—Arrhythmia—Triamcinolone—multiple sclerosis	0.000211	0.0164	CcSEcCtD
Dipivefrin—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000211	0.0164	CcSEcCtD
Dipivefrin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000203	0.0158	CcSEcCtD
Dipivefrin—Hypertension—Prednisolone—multiple sclerosis	0.000193	0.015	CcSEcCtD
Dipivefrin—Arrhythmia—Betamethasone—multiple sclerosis	0.000192	0.0149	CcSEcCtD
Dipivefrin—Arrhythmia—Dexamethasone—multiple sclerosis	0.000192	0.0149	CcSEcCtD
Dipivefrin—Pain—Mitoxantrone—multiple sclerosis	0.00019	0.0148	CcSEcCtD
Dipivefrin—ACHE—brain—multiple sclerosis	0.000184	0.034	CbGeAlD
Dipivefrin—Tachycardia—Prednisolone—multiple sclerosis	0.000178	0.0139	CcSEcCtD
Dipivefrin—Hypertension—Triamcinolone—multiple sclerosis	0.000178	0.0138	CcSEcCtD
Dipivefrin—Hypertension—Methylprednisolone—multiple sclerosis	0.000177	0.0138	CcSEcCtD
Dipivefrin—ADRA2C—medulla oblongata—multiple sclerosis	0.000169	0.0311	CbGeAlD
Dipivefrin—Conjunctivitis—Methotrexate—multiple sclerosis	0.000169	0.0131	CcSEcCtD
Dipivefrin—Arrhythmia—Prednisone—multiple sclerosis	0.000167	0.013	CcSEcCtD
Dipivefrin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000164	0.0128	CcSEcCtD
Dipivefrin—Tachycardia—Triamcinolone—multiple sclerosis	0.000164	0.0127	CcSEcCtD
Dipivefrin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000164	0.0127	CcSEcCtD
Dipivefrin—Hypertension—Betamethasone—multiple sclerosis	0.000161	0.0125	CcSEcCtD
Dipivefrin—Hypertension—Dexamethasone—multiple sclerosis	0.000161	0.0125	CcSEcCtD
Dipivefrin—BCHE—medulla oblongata—multiple sclerosis	0.000158	0.0291	CbGeAlD
Dipivefrin—Pain—Prednisolone—multiple sclerosis	0.000156	0.0121	CcSEcCtD
Dipivefrin—ADRA2C—midbrain—multiple sclerosis	0.000155	0.0285	CbGeAlD
Dipivefrin—ADRA2C—spinal cord—multiple sclerosis	0.000151	0.0278	CbGeAlD
Dipivefrin—Tachycardia—Dexamethasone—multiple sclerosis	0.000149	0.0116	CcSEcCtD
Dipivefrin—Tachycardia—Betamethasone—multiple sclerosis	0.000149	0.0116	CcSEcCtD
Dipivefrin—BCHE—midbrain—multiple sclerosis	0.000144	0.0266	CbGeAlD
Dipivefrin—Pain—Triamcinolone—multiple sclerosis	0.000144	0.0112	CcSEcCtD
Dipivefrin—BCHE—spinal cord—multiple sclerosis	0.000141	0.0259	CbGeAlD
Dipivefrin—Hypertension—Prednisone—multiple sclerosis	0.00014	0.0109	CcSEcCtD
Dipivefrin—ADRA2A—medulla oblongata—multiple sclerosis	0.000135	0.0249	CbGeAlD
Dipivefrin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000135	0.0105	CcSEcCtD
Dipivefrin—ADRA1A—nervous system—multiple sclerosis	0.000133	0.0246	CbGeAlD
Dipivefrin—Pain—Dexamethasone—multiple sclerosis	0.00013	0.0101	CcSEcCtD
Dipivefrin—Pain—Betamethasone—multiple sclerosis	0.00013	0.0101	CcSEcCtD
Dipivefrin—Tachycardia—Prednisone—multiple sclerosis	0.00013	0.0101	CcSEcCtD
Dipivefrin—ADRA1A—central nervous system—multiple sclerosis	0.000128	0.0236	CbGeAlD
Dipivefrin—ADRA2C—nervous system—multiple sclerosis	0.000127	0.0234	CbGeAlD
Dipivefrin—ADRA1A—cerebellum—multiple sclerosis	0.000126	0.0231	CbGeAlD
Dipivefrin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000124	0.00962	CcSEcCtD
Dipivefrin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000124	0.0096	CcSEcCtD
Dipivefrin—ADRA2A—midbrain—multiple sclerosis	0.000123	0.0227	CbGeAlD
Dipivefrin—ADRA2C—central nervous system—multiple sclerosis	0.000122	0.0225	CbGeAlD
Dipivefrin—ADRA2A—spinal cord—multiple sclerosis	0.00012	0.0222	CbGeAlD
Dipivefrin—ADRA2C—cerebellum—multiple sclerosis	0.00012	0.022	CbGeAlD
Dipivefrin—BCHE—nervous system—multiple sclerosis	0.000119	0.0218	CbGeAlD
Dipivefrin—BCHE—central nervous system—multiple sclerosis	0.000114	0.021	CbGeAlD
Dipivefrin—BCHE—cerebellum—multiple sclerosis	0.000112	0.0205	CbGeAlD
Dipivefrin—ADRA1A—brain—multiple sclerosis	0.000102	0.0188	CbGeAlD
Dipivefrin—ADRA2A—nervous system—multiple sclerosis	0.000101	0.0187	CbGeAlD
Dipivefrin—Hypersensitivity—Prednisone—multiple sclerosis	9.78e-05	0.00761	CcSEcCtD
Dipivefrin—ADRA2A—central nervous system—multiple sclerosis	9.77e-05	0.018	CbGeAlD
Dipivefrin—ADRA2C—brain—multiple sclerosis	9.72e-05	0.0179	CbGeAlD
Dipivefrin—ADRA2A—cerebellum—multiple sclerosis	9.54e-05	0.0176	CbGeAlD
Dipivefrin—Pain—Methotrexate—multiple sclerosis	9.49e-05	0.00738	CcSEcCtD
Dipivefrin—BCHE—brain—multiple sclerosis	9.06e-05	0.0167	CbGeAlD
Dipivefrin—Hypersensitivity—Methotrexate—multiple sclerosis	8.18e-05	0.00636	CcSEcCtD
Dipivefrin—ADRA2A—brain—multiple sclerosis	7.75e-05	0.0143	CbGeAlD
Dipivefrin—ACHE—Metabolism of proteins—CCL2—multiple sclerosis	3.35e-05	0.000599	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—PTGER4—multiple sclerosis	3.32e-05	0.000594	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	3.3e-05	0.000591	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RGS1—multiple sclerosis	3.3e-05	0.00059	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	3.29e-05	0.000589	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—ALB—multiple sclerosis	3.29e-05	0.000588	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—CCL5—multiple sclerosis	3.24e-05	0.000579	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	3.22e-05	0.000577	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.22e-05	0.000576	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CXCR3—multiple sclerosis	3.21e-05	0.000574	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	3.2e-05	0.000572	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—CXCL10—multiple sclerosis	3.19e-05	0.000571	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—CNR1—multiple sclerosis	3.17e-05	0.000567	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—GPR65—multiple sclerosis	3.13e-05	0.000559	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CCR2—multiple sclerosis	3.12e-05	0.000558	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	3.1e-05	0.000554	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	3.08e-05	0.00055	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	3.08e-05	0.00055	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—ALB—multiple sclerosis	3.07e-05	0.00055	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	3.07e-05	0.000549	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	3.06e-05	0.000548	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—POMC—multiple sclerosis	3.06e-05	0.000548	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—POMC—multiple sclerosis	3.05e-05	0.000546	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—CCL5—multiple sclerosis	3.02e-05	0.000541	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	3e-05	0.000537	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—CCL2—multiple sclerosis	2.99e-05	0.000536	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	2.99e-05	0.000534	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—CCL5—multiple sclerosis	2.94e-05	0.000526	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—CCR5—multiple sclerosis	2.92e-05	0.000522	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	2.9e-05	0.000519	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	2.88e-05	0.000515	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	2.88e-05	0.000515	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	2.87e-05	0.000514	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	2.86e-05	0.000511	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	2.86e-05	0.000511	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	2.85e-05	0.000511	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.84e-05	0.000508	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	2.79e-05	0.000499	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—CCL5—multiple sclerosis	2.75e-05	0.000491	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—CCR5—multiple sclerosis	2.72e-05	0.000487	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—IL2RA—multiple sclerosis	2.69e-05	0.00048	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCL3—multiple sclerosis	2.68e-05	0.00048	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—IL2—multiple sclerosis	2.67e-05	0.000477	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	2.65e-05	0.000474	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—CCR5—multiple sclerosis	2.65e-05	0.000474	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	2.64e-05	0.000473	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—BCHE—multiple sclerosis	2.64e-05	0.000473	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	2.61e-05	0.000468	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—IL2RA—multiple sclerosis	2.61e-05	0.000467	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	2.59e-05	0.000464	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PTGER4—multiple sclerosis	2.58e-05	0.000462	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	2.58e-05	0.000461	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	2.55e-05	0.000456	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PGR—multiple sclerosis	2.55e-05	0.000455	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.54e-05	0.000454	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PGR—multiple sclerosis	2.51e-05	0.00045	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCL3—multiple sclerosis	2.51e-05	0.000449	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CXCR3—multiple sclerosis	2.5e-05	0.000447	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—ALB—multiple sclerosis	2.49e-05	0.000446	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—IL2—multiple sclerosis	2.49e-05	0.000446	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—CCR5—multiple sclerosis	2.47e-05	0.000443	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CD28—multiple sclerosis	2.47e-05	0.000442	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	2.46e-05	0.000441	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	2.46e-05	0.000439	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CD28—multiple sclerosis	2.44e-05	0.000437	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—IL2RA—multiple sclerosis	2.44e-05	0.000436	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	2.43e-05	0.000434	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PTGER4—multiple sclerosis	2.41e-05	0.000432	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	2.4e-05	0.00043	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	2.4e-05	0.000429	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	2.38e-05	0.000426	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PGR—multiple sclerosis	2.38e-05	0.000425	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	2.35e-05	0.00042	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CXCR3—multiple sclerosis	2.33e-05	0.000417	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CD28—multiple sclerosis	2.31e-05	0.000413	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	2.28e-05	0.000408	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCR2—multiple sclerosis	2.27e-05	0.000406	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	2.25e-05	0.000403	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	2.24e-05	0.000401	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	2.23e-05	0.000399	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	2.21e-05	0.000396	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	2.21e-05	0.000396	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	2.19e-05	0.000392	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	2.18e-05	0.00039	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	2.16e-05	0.000387	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—BCHE—multiple sclerosis	2.15e-05	0.000384	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	2.13e-05	0.000381	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	2.13e-05	0.000381	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	2.11e-05	0.000378	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	2.09e-05	0.000374	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	2.08e-05	0.000372	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	2.08e-05	0.000372	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	2.07e-05	0.00037	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—APOE—multiple sclerosis	2.05e-05	0.000367	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	2.04e-05	0.000366	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	2.04e-05	0.000365	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	2.04e-05	0.000365	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	2.04e-05	0.000364	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	2.03e-05	0.000362	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—IL2—multiple sclerosis	2.02e-05	0.000362	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	2.02e-05	0.000361	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	2.02e-05	0.000361	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	2.01e-05	0.00036	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	2e-05	0.000358	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	1.99e-05	0.000356	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	1.98e-05	0.000355	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	1.98e-05	0.000354	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	1.96e-05	0.000351	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	1.94e-05	0.000348	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	1.93e-05	0.000346	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	1.93e-05	0.000345	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	1.91e-05	0.000341	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	1.89e-05	0.000339	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	1.89e-05	0.000338	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	1.88e-05	0.000337	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	1.88e-05	0.000336	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	1.86e-05	0.000333	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	1.84e-05	0.00033	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	1.84e-05	0.000329	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—APOE—multiple sclerosis	1.83e-05	0.000328	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	1.83e-05	0.000327	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	1.82e-05	0.000325	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	1.76e-05	0.000316	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—POMC—multiple sclerosis	1.76e-05	0.000315	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CD86—multiple sclerosis	1.74e-05	0.000312	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	1.74e-05	0.000311	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	1.73e-05	0.000309	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	1.72e-05	0.000307	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	1.71e-05	0.000307	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	1.7e-05	0.000304	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	1.69e-05	0.000302	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	1.69e-05	0.000302	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	1.66e-05	0.000298	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	1.65e-05	0.000296	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	1.65e-05	0.000295	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	1.65e-05	0.000295	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	1.62e-05	0.00029	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	1.61e-05	0.000288	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—ALB—multiple sclerosis	1.61e-05	0.000288	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—APOE—multiple sclerosis	1.59e-05	0.000285	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	1.59e-05	0.000284	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	1.58e-05	0.000282	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	1.57e-05	0.000282	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—POMC—multiple sclerosis	1.57e-05	0.000281	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	1.57e-05	0.000281	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	1.56e-05	0.00028	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	1.55e-05	0.000277	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	1.54e-05	0.000276	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	1.54e-05	0.000276	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	1.54e-05	0.000275	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	1.53e-05	0.000274	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	1.53e-05	0.000274	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	1.52e-05	0.000272	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	1.51e-05	0.00027	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	1.5e-05	0.000269	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.5e-05	0.000269	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	1.46e-05	0.000261	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.44e-05	0.000258	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	1.44e-05	0.000258	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—ALB—multiple sclerosis	1.43e-05	0.000257	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	1.43e-05	0.000256	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	1.42e-05	0.000255	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.42e-05	0.000254	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—APOE—multiple sclerosis	1.41e-05	0.000251	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.4e-05	0.00025	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.38e-05	0.000246	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—POMC—multiple sclerosis	1.37e-05	0.000244	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.34e-05	0.000239	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	1.33e-05	0.000238	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.32e-05	0.000236	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.31e-05	0.000235	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—APOE—multiple sclerosis	1.29e-05	0.000231	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	1.29e-05	0.00023	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.28e-05	0.000229	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.28e-05	0.000229	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CD80—multiple sclerosis	1.27e-05	0.000227	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.26e-05	0.000225	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.25e-05	0.000224	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ALB—multiple sclerosis	1.25e-05	0.000223	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1.22e-05	0.000219	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.22e-05	0.000218	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—POMC—multiple sclerosis	1.21e-05	0.000216	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	1.2e-05	0.000215	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	1.2e-05	0.000214	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.19e-05	0.000212	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	1.18e-05	0.000211	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.17e-05	0.000209	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.17e-05	0.000209	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.16e-05	0.000208	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.16e-05	0.000208	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	1.16e-05	0.000207	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	1.14e-05	0.000204	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	1.12e-05	0.0002	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—POMC—multiple sclerosis	1.11e-05	0.000199	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.09e-05	0.000196	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	1.09e-05	0.000194	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.08e-05	0.000193	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	1.07e-05	0.000192	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.05e-05	0.000188	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.01e-05	0.000182	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ALB—multiple sclerosis	1.01e-05	0.000181	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	9.99e-06	0.000179	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	9.77e-06	0.000175	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	9.76e-06	0.000175	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	9.56e-06	0.000171	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	9.28e-06	0.000166	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	9.08e-06	0.000162	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	9.04e-06	0.000162	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	8.99e-06	0.000161	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL2—multiple sclerosis	8.92e-06	0.00016	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	8.88e-06	0.000159	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	8.88e-06	0.000159	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	8.87e-06	0.000159	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	8.56e-06	0.000153	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	8.45e-06	0.000151	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	8.44e-06	0.000151	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	8.4e-06	0.00015	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	8.24e-06	0.000147	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	7.99e-06	0.000143	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	7.61e-06	0.000136	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	7.51e-06	0.000134	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	7.38e-06	0.000132	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	7.34e-06	0.000131	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	7.11e-06	0.000127	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	7.07e-06	0.000126	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	7.05e-06	0.000126	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	6.99e-06	0.000125	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MYC—multiple sclerosis	6.98e-06	0.000125	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	6.96e-06	0.000125	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	6.92e-06	0.000124	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	6.86e-06	0.000123	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	6.83e-06	0.000122	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	6.82e-06	0.000122	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	6.6e-06	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	6.59e-06	0.000118	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	6.49e-06	0.000116	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	6.46e-06	0.000116	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	6.21e-06	0.000111	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	5.77e-06	0.000103	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	5.77e-06	0.000103	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	5.76e-06	0.000103	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	5.65e-06	0.000101	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	5.36e-06	9.6e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	5.35e-06	9.57e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	5.31e-06	9.51e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	5.25e-06	9.39e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL6—multiple sclerosis	5.25e-06	9.39e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	4.96e-06	8.88e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	4.34e-06	7.76e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	4.03e-06	7.21e-05	CbGpPWpGaD
